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ABSTRACT

MOTIVATIONAL INTERVIEWING: DOES IT INCREASE ALCOHOL AND
OTHER DRUG ADDICITED RETENTION IN TREATMENT
David A. Patterson
April 20, 2006
This dissertation is a post-test only comparison group study. It tests the
effects of additional Motivational Interviewing sessions during the first two weeks
in an intensive outpatient clinic. The object is to learn whether these additional
sessions will help to increase rates of treatment retention and completion with
alcohol and other drug addicted individuals as well as those who are dually
diagnosed with HIV/AIDS infection and addiction. It begins with the problems
associated with alcohol and other drugs followed by problems related to
HIV/AIDS and treatments for both illnesses. It uses Transtheoretical Stages of
Change Model as a guide for intervention development. The latter part of the
dissertation describes the method used to study this population and the results.
The dissertation is divided into five chapters. Chapter I discusses the
problems associated with alcohol and other drug addiction and HIV/AIDS
followed by treatments related to those illnesses. Chapter II begins with
reviewing the literature linked to treatment retention. This chapter identifies the
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theoretical perspectives of treatment retention and completion followed by an
intervention development using Motivational Interviewing sessions as a means to
address treatment retention and completion.
While Chapters I and II are descriptive and theoretical in nature, Chapter
III focuses on designing a study to test the effects of an intervention on retention
and completion. It lays out the methodology of the study such as its purpose,
design, instruments, sample and variables. Chapter IV discusses the results of
the study and Chapter V discusses the implications of the results.
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CHAPTER I
PROBLEM STATEMENT
Introduction
This dissertation was conducted within an intensive outpatient (IOP) clinic
at the Volunteers of America (VOA) of Kentucky Inc. The IOP clinic has existing
research infrastructure that is funded by a Substance Abuse and Mental Health
Services Administration’s (SAMHSA) Center for Substance Abuse Treatment
(CSAT) grant. The grant enabled the Volunteers of America to establish an IOP
clinic specifically to treat individuals with alcohol and other drug addiction, which,
according the SAMHSA also places them at a higher risk for HIV-infection.
The primary aim of the study is to test the effects of up to five Motivational
Interviewing (MI) sessions on treatment retention and completion delivered
during the first two weeks of treatment. A post-test only design with comparison
group—the treatment group (IOP + up to 5 MI sessions) and comparison groups
(IOP only)—was conducted. While the intention was to test the effects of a MI
intervention with those subjects with alcohol and other drug (AOD) addiction
seeking IOP services, there was also an attempt to enroll subjects who were
dually diagnosed with AOD addiction and HIV/AIDS infected.
This dually diagnosed population (i.e., AOD addicted and HIV/AIDS
infected) comprises a much smaller segment within the entire sample, but one
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that needs to be studied in order to address their needs during AOD treatment.
Enrolling and analyzing these subjects will be guided by Rounsaville, Carroll, and
Onken’s (2001) Stage 1b pilot trial study. The Stage 1b allows for a limited
number of subjects for pilot studies, 15 to 30 per cell along with establishing
treatment efficacy and support for larger clinical trials.
The Problem
Alcohol has played a major role in people's lives throughout history.
Alcoholic beverages in our society have been consumed with meals, served for
medicinal or religious purposes, used to celebrate special occasions, and served
as a social facilitator. While most individuals who drink alcohol do not develop
problems with, or dependence on, alcohol, many social workers encounter high
rates of alcohol problems among the clients they serve. Alcohol problems refer to
any situation caused by drinking which directly harms the drinker, places the
drinker at risk, or places others at risk. Alcohol use problems exist on a
continuum of severity from occasional binge drinking to alcohol abuse or
dependence.
This chapter opens with (a) this overview of the scope of the problems of
addiction to AOD, and the HIV/AIDS pandemic (Human Immunodeficiency Virus
[HIV] and Acquired Immunodeficiency Deficiency Syndrome [AIDS]). This is
followed by (b) a discussion of the financial and human costs, (c) trends in AOD
use, (d) the prevalence of HIV/AIDS, and (e) treatment for both addictions and
HIV/AIDS.
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The Alcohol and Other Drug Problem
Alcohol abuse is described as continued drinking despite adverse effects
on health, family, work or personal relationships, interpersonal problems, or
alcohol-related legal problems (National Institute on Alcohol Abuse and
Alcoholism [NIAAA], 2001). According to the NIAAA’ s web site (July, 2004)
100,000 Americans die of alcohol-related causes each year, making alcohol the
third leading contributor to mortality related to lifestyle in the U.S. (tobacco is first,
and diet and activity patterns are second). Nearly 53% of the adult population of
the U.S. (98 million persons aged 18 or older) have family histories of alcoholism
or problem drinking (July, 2004). Approximately 6.6 million children under age 18
live in households with at least one alcoholic parent.
According to SAMHSA’s 2004 National Survey on Drug Use and Health,
about half (50.3%) of Americans aged 12 years or older reported that they
consume alcohol. This converts into an estimated 121 million Americans drinking
alcohol on a regular basis coded into three categories of use: Current, (at least 1
drink in the past month), Binge use, (5 or more drinks on the same occasion in
the past month), and Heavy use (5 or more drinks on the same occasions on at
least five different days in the past month). Almost 45% (55 million) report binge
drinking and just fewer than 14% (17 million) are heavy drinkers. Almost 14
million U.S. adults meet medical criteria for the diagnosis of alcohol abuse or
alcoholism, and over 30% of high school seniors engage in binge or heavy
drinking.
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The Costs: Financial and Human
The estimated costs of alcohol disorders and their social consequences in
1998 were $185 billion. Of this sum, direct treatment and health care costs
accounted for 14%, reduced worker productivity 47%, and lost productivity due to
premature deaths for 20% (July, 2004). Costs associated with alcohol-related
traffic crashes—the fifth leading cause of death for Americans of all ages—
account for 9%, as do costs associated with criminal activity. Almost 39% of
these costs were spread across the U.S. population in the form of increased
burden on government budgets.
Fetal alcohol syndrome (FAS), a serious disorder affecting brain function,
is the leading preventable birth defect in the U.S., with an estimated incidence
rate between 0.5 to 3.0 cases per 1,000 births. A larger number of infants who do
not present with the facial features required for a FAS diagnosis, nonetheless,
experience alcohol-related neurobehavioral deficits caused by prenatal alcohol
exposure (SAMHSA, June, 2004).
While alcohol is usually studied separately from other addictive
substances, many people who have addictions may use several other
substances, including alcohol, marijuana, cocaine, and heroine. Nineteen million
Americans 12 years or older reported using illicit drugs in SAMHSA’s 2004
National Survey on Drug Use and Health; this represented just fewer than 8% of
the U.S. population. Marijuana was the most commonly reported illicit drug used
(14.6 million) followed by non-medical psychotherapeutic drugs (6 million), pain
relievers (4.4 million), tranquillizers (1.6 million), stimulants (1.2 million), and

4

sedatives (0.3 million). Table 1 shows the most popular drugs. Crack cocaine,
derived from powder cocaine, produces a euphoric high in less than 10 seconds
and costs approximately $100 per gram. Marijuana is a plant (cannabis sativa)
when harvested, dried and smoked causes the effect of relaxation as well as
extreme paranoia. Marijuana is sold in multiple ways from one joint to pounds,
which could cost up to $1,500. Alcohol’s chemical makeup consists of ethanol
(CH3CH2OH) and is sold in various forms. When drunk, it reduces anxiety and
causes drowsiness. Heroin is synthesized from morphine and is a central
nervous system depressant and pain reliever. Its costs could be up to $125 per
gram. Methylenedioxy-y-N-methylamphetamine (MDMA) commonly referred to
as Ecstasy, produces profound positive feelings and relaxation. It is usually sold
in pill form and can cost approximately $25 per pill.
Alcohol and Drug use Trends
The National Institute on Drug Abuse (NIDA, 2004) and SAMHSA have
sponsored several national surveys to track drug use trends since the 1970s.
One of the most widely known is the National Household Survey on Drug Abuse
(2004), which interviewed persons age 12 and older about drug and alcohol use.
In 1991, the survey was expanded to include civilians living on military
installments, in college dormitories, and in homeless shelters. In 1979, 14.1% of
the population age 12 and older reported using an illicit drug in the past 30 days.
Between 1999 and 2001, past month illicit drug use for persons age 12 and older

5

Table 1
The Most Popular Drugs Abused, by Names, Chemical Makeup, Cost per
Unit, and Effects on Users, Ranked by Desirability in the Drug Culture

1

Street
Names
of Drugs
Crack
Cocaine
(Coke,
rocks)

Chemical
Makeup

Picture

Approximate.
Cost per Unit

Effects on Users

A form of
cocaine base,
is derived
from powder
cocaine

$100/Gram

Produces a euphoric
effect high in less
than 10 seconds

2

Marijuana
(Pot,
weed,
joints,
grass)

From the plant
cannabis
sativa

$1,500/pound

Could manifest itself
in various ways, from
relaxation to paranoia

3

Alcohol

Ethanol,
CH3CH2OH

Various

Reduces anxiety and
makes people drowsy

4

Heroin
(smack,
junk,
black tar)

Synthesized
from morphine

$125/Gram

5

MDMA
(Ecstasy,
X, Adam,
and
Essence)

MDMA (3,4methylenediox
y-Nmethylamphet
amine)

$25/Pill

A central nervous
system depressant
that relieves pain and
induces sleep. It
produces a dreamlike
state of warmth and
well-being.
Produces profoundly
positive feelings,
empathy for others,
elimination of anxiety,
and extreme
relaxation.

increased from 6.3% to 7.1%. In 2001, an estimated 0.7% of the population age
12 and older reported using cocaine, including crack, at least once in the past
month. Such use peaked in 1979 for 18-25-year-olds at 9.9, in 1982 for 12-17-
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year-olds at 1.9%, and in 1985 for 26-34-year-olds at 6.3%. In 2001, the
percentage of Americans reporting marijuana use at least once in the past month
was 5.4% of the population age 12 and older. Reported use of marijuana in the
past month peaked in 1979 for 12-17-year-olds at 14.2%; for 18-25-year-olds at
35.6%; and for 26-34-year-olds at 19.7%.
The Prevalence of HIV/AIDS
This section provides a primer on AIDS—chronicling the prevalence of
HIV/AIDS internationally, in the United States, and Kentucky. This section closes
by showing the devastating connection between HIV/AIDS, and addiction to
AOD. Although there is a substantial body of literature addressing major
milestones of the HIV/AIDS pandemic since its beginning (Bawa, 2005; del Rio,
2005; Genuis & Genuis, 2005; Shilts & Greider, 2000), discussion will be limited
to the above stated issues.
HIV/AIDS Internationally
Current estimates are that 38 million people were living with HIV infection
at the end of 2003 and that the epidemic continues to expand in almost all
regions of the world, with approximately 4.8 million new infections in 2003 (Joint
United Nations Programme on HIV/AIDS, 2004). The burden of disease in this
pandemic is disproportionately high among women and those who live in poverty.
The proportion of infected persons who are women has increased steadily so
that now more than 50% of those living with HIV are female. Adolescents and
young adults aged 15-24 years account for half of all new infections worldwide,
and girls and young women are particularly vulnerable. In Sub-Saharan Africa,
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women account for 57% of infected adults and 75% of the infections in young
adults. Though a large proportion of HIV-infected adults in the U.S. are men,
women now account for 25% of all HIV infections in North America (CDC, 2004a;
CDC, 2004b; Kaiser Family Foundation, 2004).
HIV/AIDS in the United States
The HIV/AIDS epidemic continues to be a major problem for U.S. citizens
with approximately 1 million Americans HIV/AIDS infected (CDC, 2002).
According to the Centers for Disease Control and Preventions (CDC, 2002) AIDS
incidence increased throughout the 1980s, declined from the mid-1990s through
2001, and increased 2% in 2002 (over 2001). AIDS prevalence, or the number of
persons living with AIDS in the U.S., continues to increase and was estimated to
be 384,906 at the end of 2002 (CDC, 2002). Although HIV has historically been
most prevalent among men who have sex with men (MSM, Bacon et al., 2006;
Catania, Osmond, & Stall, 2002; Celentano et al., 2006), most new HIV infections
are reported among MSM who are also injection drug users. The proportion of
HIV cases acquired through heterosexual contact has also increased, and is
equal to the proportion of cases attributed to injection drug users (CDC, 2002;
Karon et al., 2001).
Some minority groups within the U.S. are also disproportionately affected.
For example, approximately 50% of those living with HIV/AIDS are Black and
10% are Hispanic (Kentucky HIV/AIDS Surveillance Report, 2002; Zaidi et al.,
2005). The geographic distribution of people living with AIDS has also changed
as the epidemic has become more generalized. By the end of 2002, 39% of
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persons living with AIDS in the U.S. resided in the South, 29% in the Northeast,
19% in the West, 10% in the Midwest, and 3% in the U.S. territories (Kentucky
HIV/AIDS Surveillance Report, 2002).
Reports of women being infected with HIV has tripled since mid-1980,
mainly resulting from heterosexual exposure and secondarily through injection
drug use (CDC, 2002). Minority groups are the most affected by HIV associated
with drug injection and Blacks and Hispanics account for approximately 70% of
all new U.S. AIDS cases (CDC, 2002).
HIV/AIDS in Kentucky
The prevalence of HIV/AIDS in Kentucky is comparable to national trends.
As of December 31, 2004 there have been 4,119 AIDS cases reported in
Kentucky to the Department for Public Health’s HIV/AIDS surveillance system. Of
these reported cases, only 2,245 were still reported as living as of 2004. In 2003,
there were 195 new AIDS cases diagnosed. As of December 2004, 158 new
AIDS cases were diagnosed and reported to the Kentucky HIV/AIDS surveillance
programs in 2004. Kentucky ranked 31st among the United States in the number
of AIDS cases reported in 2002 (7.5 per 100,000).
The Kentucky HIV/AIDS Semi-Annual Report (2004) presents data
regarding AIDS cases diagnosed and reported to the Kentucky Department for
Public Health, HIV/AIDS Program through December 31, 2004. Kentucky,
however, did not report HIV cases until last year and is currently updating its
reporting system to reflect both HIV and AIDS. According to state regulation 902
KAR 2:020, Section 7 of the Kentucky Annual Report (KAR), health professionals
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licensed under KRS chapters 311 through 314, health facilities licensed under
KRS Chapter 216B and laboratories licensed under KRS Chapter 333 are
required to report HIV and AIDS cases to the Kentucky Department for Public
Health within five business days of diagnosis. AIDS cases are reported by name,
while HIV cases were previously reported by a unique identifier consisting of the
person's initials of last and first names, date of birth, and last four digits of their
Social Security numbers.
However, the reporting system for HIV cases has changed. On July 13,
2004 new HIV/AIDS reporting requirements were adopted in Kentucky to include
reporting for HIV using a confidential name based reporting system. According to
902 KAR 2:020 Section 7, HIV cases are to be reported by name, gender, race,
and risk factor as identified by the CDC. Data from the HIV confidential name
based reporting system, which was implemented as a result of these
requirements, will not be released until a complete evaluation of the system has
been completed. HIV tests can be either anonymous or confidential; however,
only confidential HIV positive cases are reported to the Kentucky Department for
Public Health. This new system of reporting will provide the state with more
accurate data on those who are HIV-infected and not just limited to only reporting
AIDS cases.
Demographic Trends
The Kentucky 2004 HIV/AIDS Semi-Annual Surveillance Report (2004),
which just accounts for AIDS reported cases (not HIV), indicates that 80% of all
Kentucky AIDS cases reported are male, 20% female. AIDS cases by race show
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that the majority of infected individuals are White (58%), with African Americans
making up 35% of AIDS cases while representing only 7.3% of the state’s
population (U.S. Census Bureau, 2004). Almost half of the state’s AIDS patients
(46%) were reported to live in the North Central region of the state, which
includes the Louisville Metro area. Cases reported by risk factors in 2004
indicated that men who have sex with other men are at the highest risk (47%)
followed by intravenous drug users (17%), and risk factors for 16% were
undetermined. In 2002, the AIDS rate for African-Americans was approximately
seven times higher than for whites in Kentucky. The AIDS incidence rate for
African Americans has been gradually declining since 2000 with a slight increase
observed in 2001. The AIDS rate among white Americans, which had steadily
declined since 1996, increased for the first time in 2001 and continued through
2002. Overall, AIDS rates for white Kentuckians has remained relatively stable.
The AIDS rates for African-American males in Kentucky are seven times higher
than white males in Kentucky and African-American females in Kentucky have
AIDS rates 13 times higher than white females in Kentucky (Kentucky 2004
Kentucky HIV/AIDS Semi-Annual Surveillance Report).
In 2002, AIDS was the 22nd leading cause of death for all Kentuckians.
AIDS was the 11th leading cause of death in African Americans and the 25th
leading cause of death of Whites in Kentucky (Kentucky 2004 HIV/AIDS SemiAnnual Surveillance Report). For African American males in Kentucky, AIDS
ranked as the 9th leading cause of death. In 2002, among those ages 25-44,
AIDS was the 6th leading cause of death. Among those ages 25-44, AIDS
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ranked as the 2nd leading cause of death for African American males, 7th among
white males, 5th among African American females, and 11th among white
females. In 2002, death rates among 25-44 year old White males and females
increased while death rates among 25-44 year old African-American males and
females decreased (Kentucky HIV/AIDS Semi-Annual Surveillance Report,
2004).
In 2004 the largest number of AIDS cases (46%) residing in Kentucky at
the time of diagnosis were in the North Central Area Development District (ADD),
which includes the Louisville Metro area (Figure 1). The Bluegrass ADD had the
second largest number of AIDS cases (19%) reported in Kentucky, which
includes the city of Lexington, followed by the Northern Kentucky ADD with the
third largest number of AIDS cases (8%) reported in Kentucky (Kentucky 2004
HIV/AIDS Semi-Annual Surveillance Report, 2004).

Figure 1. Number of AIDS cases in Kentucky.
12

This supports findings that those who use alcohol are more likely to
engage in behaviors that place them at higher risk for contracting HIV/AIDS
(Metzger, Navaline, & Woody, 1998; Stein, Hanna, & Natarajan, 2000); Windle,
1997). There are high rates of intravenous drug users among alcoholics in
treatment (Metzger et al., 1998) and drug-related risk behavior, i.e. needle
sharing and unprotected sex, increase along with the increase of alcohol
ingestion (Stein, Hanna, & Natarajan, 2000). There is also a link between a
history of heavy AOD use (Baseman et al., 1999; Deren et al., 1996; Hansen et
al., 2002; Logan et al., 2003; Surratt, Inciardi, Kurtz, & Riley, 2004) and the
tendency toward a lifetime of high-risk sexual behaviors, which include multiple
sex partners, unprotected intercourse, sex with high-risk partners, and the
exchange of sex for money or drugs (Avins et al., 1994; Boscarino et al., 1995;
Windle, 1997).
The Importance of Studying Addiction & HIV/AIDS Together
The role played by alcohol consumption as a facilitator of HIV/AIDS
infection risk has been the subject of much research. A relationship between
alcohol use and HIV/AIDS risk has been documented among men who have sex
with men (Bacon et al., 2006; Celentano et al., 2006; & Koblin et al., 2003), urban
minority groups (Norris & Ford 1999), adolescents (Kerr & Matlak, 1998), HIVseropositive individuals (Marks, Crepaz, Senterfitt, & Janssen, 2005), seriously
mentally ill persons (Tucker et al., 2003), and non-U.S. populations.
Twenty-nine to 60% of HIV-infected patients develop an AOD addiction at
some point in their lives—a rate roughly three times as high as that of the U.S.
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population (Meyerhoff, 2001). According to Petry (1999), the prevalence of
addiction among current HIV-infected individuals is nearly 12%--approximately
twice the rate of the general population.
The connection between alcohol and other drug addiction and HIV/AIDS
has been established, including the role of AOD use in the continuing spread of
HIV/AIDS. The Center for Substance Abuse Treatment (2002) identified five
important issues related to AOD and HIV/AIDS: (a) substance abuse increases
the risk of contracting HIV due to the association between the use of dirty
needles and engaging in risky sexual behaviors in exchange for drugs and/or
money, (b) substance abuse increases risks for obtaining substances while
under the influence or while under coercion, (c) substance abuse and HIV/AIDS
both serve as potential catalysts or obstacles in the treatment of the other, (d)
substance users who inject drugs represent the largest HIV-infected population in
the U.S., and (e) putting clients in substance abuse treatment, along with a
continuum of care, minimizes the risk of substance abuse and HIV infection
(2002). In order to stop the spread of HIV/AIDS without a vaccine, those who are
infected with the disease must stop passing it along. One of the best ways to
stop the spread of the disease is for patients to enter and engage in treatment
that lowers the risks for exposing others.
Treatments
This section chronicles the history of treatment for alcohol and other drug
addictions and the three main levels of treatment. The history of treatment for
HIV/AIDS is then described, and finally, the complexity of treating individuals
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unfortunate enough to need treatment for both conditions—addiction and
HIV/AIDS—is briefly addressed. While there are other exclusive bodies of
literature regarding addiction to and treatments of specific, individualized
substances such as nicotine (i.e. Lancaster & Stead, 2006; Roozen et al., 2006)
or opiate addiction (i.e. Ashworth, 2005; Sorensen et al., 2005) those distinctive
addictions are not addressed in this study.
The History of Addiction Treatments
The addiction treatment field in the U.S. has a history of disagreeing about
the best model or design for treating the addicted individual, resulting mainly from
the disagreement about the causes of addiction. Alcoholism’s causes have been
rooted in personal choice (Fingarette, 1988), sociocultural influences (Cahalan,
1987), family of origin pathologies (Steiner, 1971), and social learning (Peele,
1985), as well as biochemical dysfunctions (Milam & Ketcham, 1981). Alcohol is
one of the oldest, most often used drugs. The problems associated with using
alcohol are described in the Bible:
Whose heart I filled with anguish and sorrow? Who is always fighting and
quarrelling? Who is the man with bloodshot eyes and many wounds? Is it
the one who spends long hours in the taverns trying out new mixtures.
Don’t let the sparkle and the smooth taste of strong wine deceive you. For
in the end it bites like a poisonous serpent; it stings like an adder. You will
see hallucinations and have delirium tremens, and you will say foolish,
silly things that would embarrass you no end when sober. You will stagger
like a sailor tossed at sea, clinging to a swaying mast. And afterwards you
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will say. I didn’t even know it when they beat me up . . . let’s go and have
another drink. (Proverbs 23: 29-35, The living Bible)
Just as the problems connected to drinking alcohol have a long history, so do the
proposed solutions. One of the oldest solutions has been to modify individuals’
behavior and moral codes. This moral perspective sees drinking as a willful act
that violates socially acceptable norms, but which can be controlled by individual
choice (Connors & Rychtarik, 1989). The moral view of addiction remains
prevalent today (just say no) resulting in the civilization of addiction and the everincreasing prison population.
Following the moral viewpoint of addiction was the temperance movement
that emphasized controlled use of alcohol. As the use of alcohol began to spread
and people in the late 18th century and into the 19th century died from alcoholism,
the temperance movement changed from moderation of consumption to total
abstinence (Maxwell, 1950). The viewpoint stemming from the temperance
movement was that the cause of alcohol problems was the presence of alcohol.
The natural progression from this perspective was to ban the manufacture, sale,
transportation, and importation of alcohol, better known as the 18th Amendment
to the Constitution and the beginning of prohibition. While alcohol consumption
decreased under prohibition, the law was difficult to enforce and widely
unpopular and ignored.
A few years after the repeal of prohibition, Alcoholics Anonymous (AA)
was founded in 1935 by two alcoholics who were attempting to recover on
spiritual principles—a stockbroker and a physician. One of the founders, Bill
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Wilson, had experienced a spiritual awakening resulting from his experience with
the Oxford Group fellowship, a religious movement that thrived briefly in the
1930s. The Oxford Group meetings consisted of small group discussions where
confessions, talking out emotional problems, and praying to God took place
(Trice, 1958). While the Oxford movement was centered on a religious
conversion, AA (n.d.) began to see alcoholism as an illness—the moral crusade
was coming to an end.
Around the same time, the medical community became interested in
alcoholism. In an attempt to study alcohol problems through scientific work, the
Research Council on Problems of Alcohol was established in New York (Keller,
1976). While the research council did not receive any funds to study the
problems associated with alcohol, it did result in de-moralizing the problem and
set the stage for the federal government to create a bureaucracy around
alcoholism. The first federal fund established to deal with alcohol problems was
the National Institute of Alcohol Abuse and Alcoholism (NIAAA) and within a
short period of time millions of dollars were directed toward combating
alcoholism.
Current Treatments
Addiction treatment is currently designed to begin with medically
supervised detoxification, followed by some type of rehabilitation services lasting
from a few weeks up to possibility more than a year. The criteria for diagnoses
using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
(American Psychiatric Association, 1994), requires the presence of three or more
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of the following: increased tolerance (can hold more and more), withdrawal,
drinking alcohol in larger amounts, the desire to cut down the amount of alcohol
use, a great deal of time invested in obtaining or using alcohol, reducing social
activities that include drinking alcohol, and continued use despite physical or
psychological problems.
The three levels of care for the treatment of addiction are inpatient,
intensive outpatient (IOP), and outpatient. All three levels include activities such
as group and individual counseling, addiction education sessions, basic life skills
education, and engagement with 12-step meetings. Inpatient treatment is the
highest level of care—residential services lasting approximately one month.
Intensive outpatient services may include daily and possibly weekend services
lasting several hours per day over a period of many months. Outpatient treatment
is the lowest level of care and is designed for those who work and have stable
employment and social supports.
The History of HIV/AIDS Treatments
Although the virus was initially identified in the 1980s the infection in
human beings probably originated as early as the 1950s, spreading in an
epidemic way in the 1970s (Zhu et al., 1998). While there are many theories
concerning the exact origin of HIV, Gao et al.,(1999) recently discovered a
subspecies of chimpanzees in Africa carrying the HIV-1 virus, which was
introduced to humans and is responsible for the current pandemic. The
researchers concluded that hunters were exposed to infected blood. The first
cases of AIDS during the 1980s puzzled physicians because healthy young
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homosexual men were showing up in hospitals with the presence of a rare
infection found only in severely immunocomprimised people. Several cases were
published identifying pneumonia from Pneumocystis carinii, an ordinary organism
rarely causing infection, along with invasive Kaposi sarcoma, a strange cancer
that was usually localized (Treisman & Angelino, 2004). In the early years of the
disease, treatment focused mainly on palliative care—keeping the patient
comfortable. Although HIV infection continues to have a dismal outcome, in the
early 1990s, antiretroviral drugs were developed and prescribed. One of the first
drugs used was Azidothymidine (AZT), which added about 18 months to the lives
of HIV-infected individuals (Treisman & Angelino, 2004).
As research progressed and new drugs entered the market,
pharmaceutical treatments consisted of a cocktail of drugs regimented for
effectiveness. This highly active antiretroviral therapy, better known as HAART,
had to have 90% compliance to the regimen in order to be effective (Treisman &
Angelino, 2004). With these antiretroviral therapies, people with HIV/AIDS can
have lively, productive lives. The Ryan White Act provides funds for addiction
treatment but it is totally separate from medical care. Unfortunately, little is known
about the effectiveness of many treatment approaches—one of the reasons for
this study.
Combining Addiction and HIV/AIDS Treatment
Because both of these conditions are complex and chronic by themselves,
it is important to have experienced AOD practitioners on staff when treating
addicted HIV-infected individuals. Integrating care for addicted HIV-infected
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individuals is, at best, difficult. Regardless of whether they enter medical care or
alcohol and drug treatment and due to limited training, providers may disagree on
which chronic disease has priority (Patterson et al., 2004). In order to accomplish
integrated care for addicted HIV-infected persons, connections must be made
between the two providers, which enhance access to care and expansion of
integrated services (Selwyn & O’Connor, 1992).
Alcohol and drug treatment providers should be able to conduct HIV risk
assessments, provide basic HIV education and counseling, and provide HIV
testing with pre- and posttest counseling (CDC, 1993). The staff within the
primary medical care facility should ask questions regarding alcohol and drug
use, have cultural competence training, and reinforce the message to patients
that any AOD use damages their overall health and is cause for referral to be
assessed for alcohol and drug problems (Patterson, 2004). Unfortunately,
integrated services are few and far between. While there has been an attempt at
medical and alcohol and drug providers working together, this type of
recommended care is still nonexistent in the Louisville, Kentucky area.
The next chapter provides a comprehensive review of relevant literature.
Retention in treatment and theoretical perspectives are highlighted.
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CHAPTER II
REVIEW OF RELATED LITERATURE
This chapter first focuses on treatment retention and completion for both
populations under study (those addicted to AOD and persons with HIV/AIDS).
Theoretical perspectives are then examined and Motivational Interviewing as an
intervention to increase retention is presented. This chapter closes with
explication of the gap in the professional literature that this study is designed to
address.
Treatment Retention and Completion Linked to Better Outcomes
Research links treatment retention and completion to lower alcohol use,
which in turn, decreases the risk for spreading HIV (e.g., Basso & Bornstein,
2000; Moos, 2003). Treatment retention and completion have been consistently
confirmed to improve outcomes (e.g., Hubbard et al., 1996; Simpson, 1981).
Since time in treatment and treatment completion are generally associated with
more successful outcomes, identification of factors related to treatment retention
is important. Unfortunately, however, treatment dropout in the U.S. is also a wellknown phenomenon. According to Hubbard et al.,(1989), approximately 82% of
the clients in outpatient, drug free programs drop out before completing
treatment. More recent findings of high dropout rates across treatment modalities
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indicate that clients usually do not remain in treatment for more than a couple of
weeks (Anglin & Hser, 1990).
Rationale for Studying Retention
Retention and completion of addiction treatment have been widely
recognized as factors contributing to improved post treatment alcohol and other
drug abstinence. While adaptations of Motivational Interviewing (Miller & Rollnick,
2002) have demonstrated promise in improving treatment adherence, including
retention (Zweben & Zuckoff, 2002), no studies on methods were found to
improve retention and completion among those who were HIV-infected. Given
the established health threat related to the spread of AIDS by those who are
dually diagnosed with HIV-infected and actively abusing alcohol, this is a serious
concern (Basso & Bornstein, 2000). Thus, the overall purpose of the study is to
test the effects of up to five motivational interviewing sessions on the retention
rates for addicted HIV-infected individuals entering an intensive outpatient
alcohol and drug treatment program.
Retaining HIV-Infected Alcohol Dependent Individuals in Treatment
Although Zweben and Zuckoff (2002) made a case for using Motivational
Interviewing with AOD addicted individuals in order to improve their retention and
completion, there is an absence of empirically based practice methods that focus
on retaining HIV-infected alcohol-dependent individuals in treatment. The
majority of studies of HIV-infected individuals with addictions center on retention
in methadone maintenance programs.
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While past studies addressed HIV-infected individuals’ retention in care
services, few dealt specifically with retaining addicted individuals in alcohol and
drug treatment settings. The efficacy of motivational interviewing with HIVinfected alcohol dependent individuals has not been evaluated.
Hypotheses
Two hypotheses were posed for this study which pertained to the paucity
of research on the potential of MI to increase number of days in treatment:
Therefore, the hypothesis posed and tested are: Up to five booster
motivational interviewing sessions during the first two weeks of treatment
increases (a) days in IOP treatment, and (b) completion rates in an
intensive outpatient alcohol and drug treatment program in a Volunteers of
America treatment program.
Theoretical Perspectives on Treatment Retention
This section provides theoretical perspectives regarding treatment
retention. It begins with (a) Carl Rogers’ perspective, (b) Prochaska’s
Transtheoretical Stages of Change Model, (c) Miller & Rollnick’s perspective of
Motivational Interviewing, (d) designing an intervention using Motivational
Interviewing, and ends with (e) the gap in knowledge.
Carl Rogers’ Therapy and Therapeutic Relationship
Motivational Interviewing was birthed out of Carl Roger’s approach to
counseling. Carl Rogers’ main idea about humanity is that every one of us has
one ultimate motivating force – self-actualization. He defined this event as the
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inherent tendency of the organism to develop all its capacities in ways that serve
to maintain or enhance the organism (1951, 1961, & 1980).
According to Rogers we are born with a positive valuing process that
enhances and maintains the positive things in our lives, and devalues negative
experiences that stagnate our growth potential. With this internal process that is
part of our inherent design, we trust that they intend to serve us well. Rogers
concluded that our worlds are products of our own making (our realities) and that
in order for someone else to understand our real reality they must attempt to
place themselves in our frame of reference (1951, 1961, & 1980). Once we
understand ourselves, we seek positive regard for that self. People learn to need
others and to be needed, loved, prized, and accepted. These needs are addictive
and can become the most important thing in becoming a person.
For instance, when parents respond to children’s behaviors with positive
reflection, the children see that their behavior evoked a pleased parent and they
try to do it again. But if parents respond negatively, children see their loving
relationships with their parents weakening. Before long, as children grow, they
see themselves as others regard them. This results in individuals seeing
themselves as more or less worthy, depending on the responses they received
from their parents and others.
Individuals with maladjusted conditions of worth are threatening to
themselves. Because we all deserve full self-actualization and to become whole
persons, if our behavior is conflicted with the self we like and the self we dislike,
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then we have divided personalities that can result in dysfunction (1951, 1961, &
1980).
The most important ingredient for therapy, according Rogers, is the
therapeutic relationship. As stated earlier, Motivational Interviewing’s techniques
are founded in Rogers’ therapy and his relationship beliefs with clients. He uses
terms such as unconditional positive regard, empathy and genuineness. Without
the therapist succeeding in these relationship issues, Rogers’ therapy falls apart.
Because of his theory behind personality and people seeking self-actualization, if
the therapy session’s atmosphere does not provide unconditional positive regard
for the client, then harm will result.
Transtheoretical Stages of Change Model
The Transtheoretical Stages of Change Model (Prochaska & DiClemente,
1982, 1984) described a behavioral change model that can be generally applied
to explain treatment retention. Their work consists of how and why people
change on their own as well as with some type of professional assistance. They
set out to describe a set of predictable stages through which people travel in the
course of altering addicted behavior: Preconception, Contemplation,
Determination, Action, and Maintenance. These stages of change, however, are
not without criticism. In a review of research on the transtheoretical model, Littell
and Girvin (2002) observed that empirical evidence suggests that the proposed
stages of change are not discrete, and there is little empirical evidence showing
sequential transitions through the stages. The researchers proposed that change
can come about swiftly, often as a result of life events or external pressures,
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rather than a progression through stages. Nonetheless, the transtheoretical
model is widely accepted and prescribed due to its useful heuristic view of
change. Within this approach, motivation can be seen as a client’s present state
or stage of readiness for change. Several researchers have demonstrated that
an adaptation of Motivational Interviewing can be effective at influencing stages
of change including treatment compliance and retention (e.g. Zweben & Zuckoff,
2002).
Prochaska and DiClemente (1982, 1984, & 1986) created five criteria for
the transtheoretical model. First, a sophisticated integration must respect both
the fundamental diversity and essential unity of psychotherapy systems. Second,
the model should emphasize empiricism by measurable variables, and be
validated. The third criterion was to account for how some people recover from
clinical disorders without the help of professionals. Fourth, the model should
generalize to a broad range of human problems. And finally, the transtheoretical
model should encourage psychotherapists to be innovators, rather than simply
borrowing from other systems (Prochaska, Norcross, & DiClemente, 2002).
Stages of Change
Five stages of change have been conceptualized for a variety of problem
behaviors: Precontemplation, Contemplation, Preparation, Action, and
Maintenance (Prochaska & Norcross, 2003). One of many reasons for using this
in an AOD program is its natural connection with the 12 steps of Alcoholics
Anonymous (AA). While there will be a discussion of these theories later, the 12
steps of AA (n.d.) are listed below to show how they would fit these stages.
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Precontemplation is the stage in which people are not intending to take
action in the foreseeable future, usually measured as the next six months.
People may be in this stage because they are uninformed or under-informed
about the consequences of their behaviors. Or they may have tried to change a
number of times and become demoralized about their ability to change. Both
groups tend to avoid reading, talking or thinking about their high-risk behaviors.
They are often characterized in other theories as resistant or unmotivated or as
not ready for treatment. Traditional therapeutic programs are often not designed
for such individuals and are not matched to their needs (Prochaska, Norcross, &
DiClemente, 2002).
Contemplation is the stage in which people are intending to change in
the next six months. They are more aware of the pros of changing but are also
acutely aware of the cons. This balance between the costs and benefits of
changing can produce profound ambivalence that can keep people stuck in this
stage for a long time. Those finding themselves in this stage are characterized as
chronic contemplators or behavioral procrastinators. These people are also not
ready for traditional action oriented programs and could account for many
treatment dropouts (Prochaska, Norcross, & DiClemente, 2002).
Preparation is the stage in which people are intending to take action in
the immediate future, usually seen as the next month. They have typically taken
some significant action in the past year. These individuals have a plan of action,
such as joining a health education class, consulting a counselor, talking to their
physicians, buying self-help books. or relying on self-change approaches. These
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are the people who should be recruited for action-oriented smoking cessation,
weight loss, or exercise programs (Prochaska, Norcross, & DiClemente, 2002). .
The first three AA steps are undertaken in this stage:
1.

We admitted we were powerless over alcohol - that our lives had become
unmanageable.

2.

We came to believe that a power greater than ourselves could restore us
to sanity.

3.

We made a decision to turn our will and our lives over to the care of God
as we understood Him.
Action is the stage in which people have made specific overt

modifications in their life-styles within the past six months. Since action is
observable, behavior change often has been equated with action. But in the
Transtheoretical Model, Action is only one of five stages. Not all modifications of
behavior count as action in this model. People must attain a criterion that
scientists and professionals agree is sufficient to reduce risks for disease. In
smoking, for example, the field used to count reduction in the number of
cigarettes as action, or switching to low tar and nicotine cigarettes. Now the
consensus is clear--only total abstinence counts. The Action stage is also the
stage where vigilance against relapse is critical (Prochaska, Norcross, &
DiClemente, 2002). AA Steps 4 through 9 are to be completed in this stage:
4.

We made a searching and fearless moral inventory of ourselves.

5.

We admitted to God, to ourselves, and to another human being the exact
nature of our wrongs.
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6.

We sere entirely ready to have God remove all these defects of character.

7.

We humbly asked Him to remove our shortcomings.

8.

We made lists of all persons we had harmed and became willing to make
amends to them all.

9.

We made direct amends to such people wherever possible, except when
to do so would injure them or others.
Maintenance is the stage in which people are working to prevent relapse

but they do not apply change processes as frequently as do people in action.
They are less tempted to relapse and increasingly more confident that they can
continue their change (Prochaska, Norcross, & DiClemente, 2002). AA Steps 10
– 12 are completed in the Maintenance stage:
10.

We continued to take personal inventory and when we were wrong
promptly admitted it.

11.

We sought though prayer and meditation to improve our conscious contact
with God as we understood Him, praying only for knowledge of His will for
us and the power to carry that out.

12.

We have had a spiritual awakening as the result of these steps; we tried to

carry this message to alcoholics and to practice these principles in all our affairs.
Prochaska’s Therapy
There is an attempt to combine the process of change and the stage.
Once the stage of change is identified in a client, then the process is applied.
Prochaska has specific recommendations for the process of change during each
stage. For example, if a client was in the Precontemplation or Contemplation
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stage, the therapist would attempt to raise the client’s consciousness and/or
dramatic relief (Prochaska & Norcross, 2003). Helping the client become more
aware of the problem and get some emotional relief would move them into the
next stage. For the Contemplation stage specifically, environmental reevaluation
and self-reevaluation are used. As clients become more aware of their problems,
they are more open to reevaluating their values and actions. The Preparation
stage utilizes self-liberation due to the client’s readiness to change. They need to
know that they have autonomy to change their lives, which is associated with
self-efficacy. Action and Maintenance stages use contingency management,
counter conditioning, and stimulus control (Prochaska & Norcross, 2003).
The Therapeutic Relationship
The transtheoretical psychotherapist is viewed not as an expert having all
of the answers, rather an expert about change. Because some of Prochaska’s
research studied how people changed without seeking professional services, the
relationship is based on the assumption that people have the ability and
capability to change. According to Prochaska, the relationship with the client
depends on the client’s current stage (Prochaska, Norcross, & DiClemente,
2002). For example, the relationship with Precontemplators should be that of a
nurturing parent who allows for independence. Contemplators would create a
Socratic or teacher position in that the therapist would encourage insight into the
problem’s conditions. Working with clients in the Preparation stage is like
coaching a specific game plan. A consultation relationship would be used for the
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Maintenance stage. This is another reason to use some of the skills of
motivational interviewing.
Motivational Interviewing
Motivational interviewing (Miller & Rollnick, 2002) is a proven practice
method that has been shown to be as effective as CBT and TSF methods, yet
much briefer and time limited. For example, Project MATCH researchers (Project
MATCH Research Group 1993, 1997a, 1997b), in a large and highly respected
randomly controlled trial (n = 1,726) concluded that an adaptation of motivational
interviewing, MET, delivered in four 1-hour weekly sessions (Miller & Rollnick,
1991) was as effective as cognitive behavioral therapy (CBT) (1997a) or twelvestep facilitation (TSF) methods (1997b) delivered across 12 weekly one-hour
sessions. Although the adaptation of MI had one-third the number of sessions as
CBT or 12-Step clients, the number of days using alcohol in the year following
treatment was substantially the same across all three methods (Glaser et al.,
1999).
MI provides an approach to explore and resolve ambivalence about
recovery. As such, MI may offer a common ground on which both AOD treatment
field and health-care providers may be able to unite and collaborate to ensure
appropriate care of HIV-infected individuals who are abusing substances. The
logic behind using MI with this clientele is that replicated clinical trials have
demonstrated what it is a brief intervention (1 to 4 sessions) that is effective at
improving substance use outcomes as well as treatment retention and
compliance (Miller & Rollnick, 2002; Zweban & Zuckoff, 2002). Miller and Rollnick
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(2002) defined MI as a way of being with people and a set of clinical methods
that can be taught and learned. MI involves the application of four basic
principles: (a) expressing empathy, (b) developing discrepancy, (c) rolling with
resistance, and (d) supporting self-efficacy, thus enhancing intrinsic motivation
related to initiating some change to a healthier behavior. MI matches specific
treatment strategies to the client’s is stage of change (Prochaska & DiClemente,
1982).
Designing a Motivational Interviewing Intervention
Denial, defensiveness, and resistance are attributes of substance abusers
and can be barriers to effective treatment. However, research has not supported
the conclusion that addicted persons, as a group, have abnormally robust
defense mechanisms (Miller, 2000). There could be several reasons for this
belief, the first being that exceptionally difficult clients are elevated to become
models of usual responses. The term “denial” is often used to describe lack of
compliance or motivation among substance users, whereas the term “motivation”
is reserved for concepts like acceptance and surrender (Kilpatrick et al., 1978;
Nir & Cutler, 1978; Taleff, 1997). According to Miller and Rollnick (1991), clients
who disagree with clinicians, who refuse to accept clinicians’ diagnoses, and who
reject treatment recommendations are usually labeled as being in denial.
A second explanation is that behaviors viewed as normal in ordinary
individuals are labeled as pathological when observed in addicted populations
(Orford, 1985). Many people use denial, resistance, arguing, and/or
rationalization as a common defense mechanism to protect themselves
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emotionally (Brehm & Brehm, 1981). Aggressive confrontation generally evokes
outright denial. Motivational Interviewing avoids the pitfalls of direct confrontation
and not allowing the client to have some selection in treatment goals. MI provides
a constructive type of therapeutic confrontation thereby helping clients assess
the reality of their behaviors, reconnect with their personal goals, and recognize
discrepancies between current behaviors and desired ideals (Ivey et al., 1997).
Nearly every client coming into the intervention will have some common defense
mechanisms which will be dealt with by using the principles of MI, i.e. focus on
client competencies and strengths, refrain from labeling, and create therapeutic
partnerships for change using empathy rather than authority and power.
Intervention Development
Rounsaville, Carroll, and Onken (2001) suggested that intervention
development begins with selection of an accepted theory or model to guide the
developers. Although MI has not been used with HIV positive patients or to
improve retention in an IOP alcohol treatment program, our approach is
consistent with Rounsaville et al.’s suggestion in that MI already stands as a
proven practice that can be adapted to treatment retention (Zweben & Zuckoff,
2002). MI has repeatedly demonstrated success in advancing clients through the
stages of change in several randomly controlled trials (Burke, Arkowitz, & Dunn,
2002). More specifically, Miller and Rollnick (1991) defined motivation as “the
probability that a person will enter into, continue, and adhere to a specific change
strategy” (p.19), and prescribed MI principles to increase and sustain motivation
to change. Interventions such as Motivational Interviewing (or adaptations using

33

these principles), have demonstrated promise in increased treatment completion
and have been shown to be an effective approach for engaging, treating and
retaining individuals with AOD addictions.
Zweben and Zuckoff (2002) reviewed 21 studies that assessed treatment
outcomes and adherence to treatment and found that a majority of the controlled
studies (12 of 21), using adaptations of motivational interviewing produced
significant positive effects on treatment adherence including treatment retention.
As a result, Zweben and Zuckoff (2002) reported that “findings of adherence
effects in the preponderance of studies leave us cautiously optimistic about
motivational interviewing as an add-on adherence intervention” (p. 306).
Miller and Rollnick (1991) contended that motivation is necessary to
proceed through stages of change, and identified several research-based clinical
principles and strategies to elicit intrinsic motivation. Walizter, Dermen, and
Connors (1999) reviewed the MI literature and supported MI’s effectiveness.
Zweben and Zuckoff (2002) concluded that it is necessary to separate the
MI intervention process into two distinct motivational problems that must be
targeted and successfully resolved in order to improve treatment adherence: (a)
alcohol problem acceptance, and (b) alcohol treatment acceptance (Daley et al
1998). Whereas problem acceptance is focused on raising intrinsic motivation to
engage in change strategies related to client’s alcohol dependence, treatment
acceptance involves facilitating motivation and commitment related to treatment
adherence.
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Commitment and Action related to problem acceptance must be in place
prior to focusing MI on treatment acceptance. Zweben and Zuckoff (2002) noted
that while there are risks associated with problem acceptance, i.e.,
misperceptions, misunderstanding or uncertainties about the presenting problem,
treatment acceptance risk factors, i.e. misperception about treatment needs,
financial or family hardships and stigmas, these can be ameliorated with MI skills.
Zweben and Zuckoff (2002) provided an exploratory framework for addressing
adherence, specifically for problem acceptance and treatment acceptance, which
was used in designing the booster intervention herein.
The Gap in Knowledge
According to SAMHSA (n.d.), women, adolescents, young adults, and
minorities continue to be under-represented in clinical services because of social,
cultural, and geographic barriers. This lack of involvement in clinical services
diminishes access to quality health care, hampers widespread adoption of
available preventive approaches, limits safe and effective management of HIV
treatment and associated complications, and jeopardizes the ability of
researchers to generalize findings to those most in need. As a result, when
applying for SAMHSA research funds they require a planned attempt at recruiting
under-represented subjects into the study.
By not excluding any subjects in this study for reasons like
homelessness, criminal justice involvement, psychiatric histories, or any other
potential problems related to excused subjects for research designs (see Project
MATCH Research Group 1997a), as well as purposefully including HIV-infected
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individuals, this dissertation will test the effects of an intervention with individuals
who seldom have the opportunity to be involved in research: The primary
scientific gap in knowledge is the specific utilization of a Motivational Interviewing
intervention with AOD addicts who are also HIV/AIDS positive. While MI has
been studied using a variety of subjects in multiple settings, i.e. medication
compliance (Adamian et al., 2004; Parsons et al., 2005; Safren et al., 2001), and
HIV risk reduction (Harding et al., 2001; Parsons, 2005), evidence-based
research is lacking on those who suffer from the dual problems of AOD addiction
and HIV-infected.
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CHAPTER III
METHODOLOGY
In September 2002, the Volunteers of America’s (VOA) intensive
outpatient (IOP) clinic in Louisville, KY received funding under SAMHSA to
enhance its addiction services for HIV-infected and high-risk populations—the
gap in knowledge previously identified. The new funding allowed VOA’s IOP
program to expand its existing treatment services and treatment outcome
research infrastructure. The program increased its original staff of one certified
alcohol and drug counselor (CADC) and one case manager to two additional
CADCs, two case managers, two associate counselors, and a child advocate to
monitor the children while their parents/guardians received treatment. The IOP
program is funded through 2007. As part of their IOP evaluation, VOA personnel,
as well as University of Louisville evaluators, obtained base line, 6-month and
12-month data with an 80% follow up requirement. Infrastructure and protocols
were in place for obtaining consent, substance abuse and safer sex outcome
measures, location and followup at six months after intake, and data entry.
This chapter is organized to first bring the reader into (a) the context of the
dissertation study. A preliminary study had just been completed that is briefly
described. Then (b) a purpose statement is provided, followed by the (c)
research design section that includes the consent procedure, inclusion criteria,
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and how clients were assigned to the treatment and comparison groups. The (d)
protocol includes subsections for the comparison and treatment groups, and the
operationalization of all variables. The research design section closes with a brief
review of analyses conducted, and limitations of the study.
Retention in IOP Prior to Current Study
During the first year of the Volunteers of America’s intensive outpatient
clinic, the vast majority of HIV-infected clients who entered the IOP program
dropped out of treatment well before completing, and the number of sessions
attended was low. The program under study was designed for 26 weeks of
primary treatment followed by approximately 26 weeks of aftercare, and includes
a total of approximately 130 treatment sessions prior to completion. The IOP
clients attend five days a week, Monday through Friday, approximately four hours
per day. The total number of male clients entering the program the first year
(2003) was 48, with 27 of those being African-Americans and 21 White. Thirtyseven were HIV-infected at the time of admission while 11 reported not being
HIV-infected. Means indicate that HIV-infected men dropped out of IOP after only
13.8 days (SD = 18.74) compared to non-infected men dropping out after 19.9
days (SD = 27.16). Although a notable difference was observed between infected
and non-infected clients, the difference was not statistically significant (t (46) = .859, p = .395).
A preliminary study at an intensive outpatient substance abuse treatment
program for those infected with HIV and served by VOA of Kentucky and
Tennessee’s Intensive Outpatient Clinic, yielded high rates of treatment dropout
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Although many agreed to and entered treatment, most abandoned treatment
soon afterwards, which prompted this study. It is hypothesized that up to five
additional “booster” sessions of an adaptation of motivation interviewing along
with intensive outpatient alcohol and drug treatment services will increase days in
treatment (retention and completion) among these dually diagnosed (substance
dependence and HIV-infected) individuals who were active in the intensive
outpatient treatment program within VOA in Louisville, KY. This dissertation was
a pilot study with posttest only comparison groups and sequential assignment to
treatment and comparison groups. An adjustment was made to balance the
groups in terms of HIV positive clients—a deviation from strict random
assignment. The intervention in the treatment group (n = 50) consisted of IOP +
up to five additional MI booster sessions, and clients in the comparison group (n
= 56).
Purpose Statement
The purpose of this study was to test the effects of up to five add on
booster MI sessions (an adaptation of MI intervention, Miller & Rollnick, 2002)
during the first two weeks of treatment—the time when most dropouts occur. The
object is to learn whether these additional MI sessions will help to increase rates
of treatment retention and completion in an intensive outpatient addiction
program with alcohol and other drug (AOD) addicted as well as individuals who
are also HIV-infected AOD. This research built upon existing research
infrastructure, and expanded an ongoing treatment longitudinal outcome study
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(sponsored by SAMHSA-Center for Substance Abuse Treatment [CSAT] TI03008) of individuals assessed as high risk for HIV or HIV-infections.
The following steps have been completed as part of the CSAT study that
has been underway since late 2003: (a) outreach workers have been trained in
MI and have been engaged in regular weekly supervision since October, 2003,
and (b) basic demographics and personal information to describe the sample and
treatment outcome measures were collected since the beginning of the study.
The dissertation represents the next step in intervention development described
by Rounsaville et al.,(2001), a stage 1b, a small, randomly controlled pilot study
of 15 to 30 subjects per group, treatment and comparison.
Research Design
The research design is posttest only comparison groups:

X

01

_______

01
where X represents the treatment of up to five additional (booster) MI sessions
within the first two weeks of IOP sessions for the treatment group of alcohol
dependent people who could also be HIV-infected, and 01 represents posttests,
or outcome measures (Campbell & Stanley, 1963). This was an intent to treat
study, meaning that subjects who were assigned to the treatment group were
analyzed, even if they did not follow through to attend any of the MI sessions.
The comparison group consisted of alcohol dependent people and who could
also be HIV-infected, and who had the same posttests but not the intervention
(X), the additional MI booster sessions. All clients were AOD dependent,
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received the intensive outpatient intervention, and were invited to participate in
the study (Appendix A).
Consent
The existing consent form (required by SAMSHA-CSAT) and the
University of Louisville’s Human Subjects Protection Program Office’s
Institutional Review Board (IRB) was amended to reflect the up to five additional
MI sessions (Appendix B). Subjects were either assigned to the additional
motivational counseling treatment condition or the comparison group consisting
of the standard IOP services.
Inclusion Criteria
Subjects (a) were 18 or older, (b) were diagnosed alcohol dependent
according to supporting documentation from referral sources or via the Addiction
Severity Index (ASI; Fureman, Parikh, Bragg, & McLellan, 1990; McLellan,
Lubrosky, Cacciola, & Griffith, 1985), (c) could read and understand English
sufficiently to complete informed consents and data collection forms, and (d)
agreed to engage in intervention activities in the VOA’s IOP program.
Assignment to Groups
Participants were assigned to treatment and comparison groups in a
sequential manner. The first eligible person was assigned to the treatment group,
the next eligible participant to the comparison group, thus altering until sample
size was achieved. Only the MI counselor who provided the MI booster
intervention was knowledgeable of the assignment. The client and IOP staff were
masked or blind to the assignment, which could have resulted in an unintended
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intervention or treatment diffusion that could have affected the results of the
study.
Protocol
The protocol for the comparison group is first described, then the
procedures for the treatment group. All subjects received the IOP services as
described here for the comparison group.
Comparison Group and IOP for all Subjects
The comparison group, those receiving the standard treatment of the
VOA’s IOP program services, received all usual and customary services
rendered by the VOA program. The only difference between the treatment and
comparison groups was the additional MI sessions.
Treatment was provided by the VOA IOP program and consisted of
weekly individual and group counseling sessions five days a week over a sixmonth period. All clients admitted to the VOA IOP program adhere to a rigorous
weekly schedule consisting of 12-step educational sessions, drug refusal skills,
life skills, treatment planning, and group therapy. Group therapy is largely
focused on engaging clients in twelve-step recovery using a highly structured
twelve-step facilitation method that is fundamentally grounded in the AA
literature. IOP clients also must attend a minimum number of Alcoholics
Anonymous meetings during the course of treatment (usually 5 meetings
weekly). All counselors are certified alcohol and drug counselors (CADC) or
within a year of obtaining certification.
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Treatment Group
Once subjects were admitted to the program and volunteered to be in the
study the MI counselor was notified. An attempt was made to schedule the first
intervention session for the treatment group the following day, which would have
been the first full day of IOP. MI sessions were available only to those in the
treatment group and were conducted between regularly scheduled IOP
counseling or educational meetings. At the beginning of the first MI session
subjects were asked if they understood the consent form and whether they had
any questions. Subjects in the treatment group were reminded that they were
selected to receive additional counseling sessions in order to improve treatment
retention and completion.
The MI counselor placed less prominence on a manualized approach to
MI, rather following Miller and Rollnick’s (2002) suggestion of remaining in the
spirit of motivational Interviewing. Miller and Rollnick concluded after several
years of experience, that “. . . we have found ourselves placing less emphasis on
techniques of motivational interviewing and ever greater emphasis on the
fundamental spirit that underlies it” (p. 33). Motivational interviewing consists of
two phases. Phase 1 focuses on identifying and strengthening clients’ existing
motivation for change, and Phase 2 seeks to consolidate clients’ commitments to
change (Miller & Rollnick, 1998).
Each session’s fundamental framework consisted of the counselor
focusing on Miller and Rollnick’s (2002) suggestion of client collaboration,
evocation, and autonomy. The counselor avoided an authoritarian relationship,
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instead, communicating in a partner-like relationship. The session also steers
clear of any attempt to insert insight or education, but elicits clients’ intrinsic
motivation. The final key component of remaining in the spirit of MI is the
awareness that change is ultimately the responsibility of the client (Miller &
Rollnick, 2002).
Because sessions were addressing treatment adherence, the counselor,
while remaining in the spirit of MI, followed Zweben and Zuckoff’s (2002)
strategies of treatment nonadherence (Appendix C). The counselor delivering the
intervention was a Ph.D. psychologist who has received extensive training and
supervision in motivational interviewing and has been using MI for 7 years.
Operationalization of Variables
The main dependent variable is the number of days in treatment. All data
were collected by the administrative assistant—the demographics in the intake
process (four items) and days in treatment when clients either completed the
program or ceased to return. The researcher entered the data into the Statistical
Package for the Social Sciences (SPSS), and then rechecked the entries.
The following section describes variables that encompass demographic
variables included age, gender, race, and HIV/AIDS status. Subjects’ ages were
provided in years at the date of admission. There are two categories of gender,
male and female. Four categories were used to describe the race of participants:
African-American, Caucasian, Native American and Hispanic. HIV/AIDS status
consisted of self-reported HIV/AIDS negative and positive. The number of MI
sessions received by the treatment group was the actual number of MI sessions
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attended by each subject (0 to 5). Operationalization of the two primary
dependent variables consisted of the actual number of IOP sessions attended (0
to 119 over six months) and treatment completion (0 = No; 1 = Yes, completed
with staff approval).
Supplemental variables were also used to assess the MI intervention dose
levels. Subjects in the treatment group could receive up to five MI sessions
during the first two weeks. These sessions (doses) were dichotomized as below
and above the median number of MI sessions (2) which resulted in 0 to 2 MI
sessions = Low dose (recoded as 0), and 3 to 5 sessions = High dose (recoded
as 1).
A counselor’s perception of severity was determined by whether subjects
were excluded from or included in the Government’s Performance and Results
Act (GRPA). Programs receiving funds from SAMSHA-CSAT are required to
enter client data into the GPRA system at three points in time (baseline, and 6
and 12 months post baseline). Once subjects are entered into the GPRA system,
an 80% followup rate is mandated. Those subjects evaluated at admission to be
high risk to locate at followup are not entered into the GPRA system, thereby
indicating subject instability. In other words, more severe is seen as those who
are more unstable and least likely to be found for following up, as required by
GPRA. Factors considered by intake counselors included poor health, recently
hospitalized, dying, homeless or in shelters, left town, in jail or running from
authorities, and no evidence of collateral contacts. A dichotomous variable (0 =
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No; 1 = Yes, Severe) was created to reflect participants’ entrance into GPRA. All
variables are operationalized in Table 2.
Table 2
Variable Categories
Variable
1 Age
2 Gender
3 Race

4 HIV Status
5 Number of MI
Sessions
6 Number of IOP
sessions attended
7 Completed IOP

8 MI Dose (number
of MI sessions)
9 Client Severity

Operationalization of
Independent Variables
Actual age in years
0 = Male
1 = Female
1 = African American
2 = Caucasian
3 = Native American
4 = Hispanic
0 = HIV-Negative
1 = HIV-Positive
Actual number of sessions
Primary Dependent Variables
Actual number of IOP sessions
attended
0 = Did not complete
1 = Completed
Supplemental Variables
0 = Below Median
1 = Above median
0 = Entered into GPRA
1 = Not Entered into GPRA

Data Level
Ratio
Nominal
Nominal

Nominal
Ratio

Ratio
Nominal

Nominal
Nominal

Data Analysis
Data analysis began with examining sample demographics, plots and
histograms of key variables. Tests of between group differences were conducted
to assess whether groups were comparable (chi square for dichotomous and
categorical variables, t-test for continuous variables). The characteristics of
subjects who were HIV/AIDS positive were described and key variables

46

analyzed. Three additional supplemental analyses were conducted to attempt to
explain results of the main hypotheses.
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CHAPTER IV
RESULTS
This dissertation tested the effects of a motivational intervention on
treatment retention of 106 clients who were addicted to alcohol and other drugs
(AOD) and enrolled in an intensive outpatient treatment program. For the
purposes of this study, retention was operationalized as both a continuous
variable (number of sessions attended prior to discharge from the program), and
a dichotomous variable representing completion status (did or did not complete
the treatment program). Description of the sample is followed by reporting results
of testing two hypotheses, first among the entire sample (n = 106) and then
among those who were HIV positive (n = 28).
Sample Description
Table 3 describes the sample in terms of age, gender, race and HIV
status by comparison group (n = 56), treatment group (n = 50) and in total (n =
106). Fifty subjects were sequentially assigned to the treatment condition, and 56
to the comparison group. Subjects’ mean age was 35 years with a range of 19 to
63 years. The sample was approximately evenly split in terms of gender with
51.9% women. The sample was racially balanced with approximately 47% of the
sample reporting that they were African American, 49% white, and 4% Hispanic
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or Native American. The vast majority of the sample were HIV negative (73%),
and 26% reported that they were HIV positive.
No significant differences were observed in a comparison of the groups
using t-tests on age and chi-square on race, gender, and HIV status, suggesting
that the groups were similar. As Table 3 indicates, the average age of both
groups was approximately 35 years. Of the 55 females entering the study,
approximately half, 26, were in the treatment group. Twenty-four of the 51 males
in the study were assigned to the treatment group. The racial mix and HIV/AIDS
status were also equally distributed. None of the demographic differences
resulted in statistically significant findings.
Table 3
Baseline Characteristics of Respondents (n = 106)
Treatment (n = 50) Comparison (n = 56)
Mean (SD)
Mean (SD)

Total (n = 106)

Age
34.7 (9.4)
19-59 (range)
n (%)

34.1 (10.1)
19-63 (range)
n (%)

34.4 (9.7)
19-63 (range)
Total

Gender
Male
24 (48.0%)
27 (48.2%)
51 (48.1%)
Female
26 (52.0%)
29 (51.8%)
55 (51.9%)
Race
African-American
24 (48.0%)
26 (46.4%)
47 (47.2%)
Caucasian
24 (48.0%)
28 (50.0%)
52 (49.1%)
Hispanic
1 (2.0%)
1 (1.8%)
2 (1.9%)
Native American
1 (2.0%)
1 (1.8%)
2 (1.9%)
HIV Status
Positive
13 (26.0%)
15 (26.8%)
28 (26.4%)
Negative
37 (74.0%)
41 (73.2%)
78 (73.6%)
Note: None of the between group differences were significant at p .05.
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Hypothesis Testing
Hypothesis 1: Subjects in the treatment group (IOP + up to 5 MI
sessions in the first two weeks) will attend significantly more IOP sessions
than those in the comparison group.
An independent sample t-test was conducted to test Hypothesis 1. In the
total sample the mean number of days in treatment was 35 (SD = 30) with a
range from 1 to 120 days (Figure 2). Forty-four subjects attended less than 20
days, a time in which most treatment dropout occurs (Anglin & Hser, 1990).
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Figure 2. Histogram of attendance for total sample.

50

Figure 3 is a histogram of attendance in days for the treatment group. The
mean number of days attended for the treatment group spent was 33 (SD = 27)
days. The distribution is positively skewed with half of the subjects in the
treatment group dropping out within the first 20 days of treatment
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Figure 3. Histogram of attendance for treatment group.

Figure 4 is a histogram representing the comparison groups’ number of
days in treatment. The comparison group had an average of 37 days in treatment
(SD = 32). While positively skewed this distribution depicts a large proportion of
people who dropped out within the first 20 days, and then a more normally
distributed group of individuals who remained beyond 20 days.
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Figure 4. Histogram of attendance for the comparison group.

Table 4 reports the sample’s mean number of days in treatment for both
conditions and the total sample. The results of the 2-tailed t-test indicated that
there was no significant difference between the mean number of days in
treatment between groups (t = .721, df = 104, p = .472, n = 106). Therefore, H1,
that subjects in the IOP program who were assigned to the treatment group
would have increased retention as measured by days in treatment, is rejected. A
power analysis with t-test yielded a medium effect size (0.5) (alpha = 0.05; delta
= 2.5698; critical t(104) = 1.6596; power = 0.8181). While not statistically
significant, the means varied in the opposite direction of what was hypothesized,
with the comparison group remaining in the program longer than the treatment
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group (mean of 37.3 days for the comparison group compared to 33 days for the
treatment group, Table 4).
Table 4
Number of Days in Treatment

Mean (SD)

Treatment (n = 50)

Comparison (n = 56)

Total (n = 106)

33 (27)

37.3 (32)

35.3 (30)

Hypothesis 2: A higher percentage of AOD addicted subjects in the
treatment group (IOP + up to 5 added on MI sessions in the first two weeks)
will complete treatment than those in the comparison group.
Overall, 75 of the subjects (70.8%) dropped out of the program before
completing, including 72% of the comparison group and 69% of the treatment
groups. Inversely, only 28% and slightly more than 30%, of the comparison and
treatment groups, respectively, completed treatment (Table 5). Chi-square tests
indicate that the intervention did not play a significant role in treatment
completion (chi-Square = .082, df = 1, p .774, n = 106) resulting in the rejection of
the hypothesis. The results are in the opposite direction of the hypothesis. The
power for f-test on Means is low, ANOVA with medium effect size (0.25) (alpha =
0.05; power = 0.7224; critical F (1,104) = 3.9324; Lambda = 6.625; Table 5).
Retention and Completion by HIV Status
As stated earlier, part of the overall purpose of the study was to test the
intervention on a sample representative of the treatment program, as well as
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Table 5
Dropout and Completion by Treatment and Comparison Groups
Treatment

Comparison

Total

% Dropout

34 (69.4%)

41 (71.9%)

75 (70.8%)

% Completed

15 (30.6%)

16 (28.1%)

31 (29.2%)

Total
49 (100.0%)
Chi-Square = .082, df = 1, p. 774

57 (100.0%)

106 (100.0%)

those who were HIV-infected. This is consistent with Rounsaville, Carroll, and
Onken’s (2001) methods of intervention development that contend that small
samples (n = 30 to 60) Stage 1b1 pilot studies are necessary as an initial step in
intervention development even though statistical power is admittedly limited.
HIV/AIDS Sample Description
Table 6 reports demographics of subjects self-identifying as being HIVinfected and entering into the IOP clinic—only those who self-identified in this
manner are included in this section. Thirteen HIV/AIDS subjects were assigned
to the treatment group, and 15 to the comparison group. On average, subjects in
this HIV/AIDS sub-sample of 28 were approximately 37 years of age (SD = 9.1).
The majority of the HIV/AIDS subjects were men (n = 19, 67.9%). The total HIVinfected sample was disproportionately made up of minorities; approximately
71% of subjects in this sub-sample were African American and 28% were White.
Nine of the total 19 males in the HIV/AIDS sub-sample were assigned to
1

Stage 1a: Therapy Development & Manual Writing
Stage 1b: Pilot trials
Stage 2: Full-scale randomized clinical trials
54

Table 6
Baseline Characteristics of HIV/AIDS Positive Respondents
Treatment (n = 13) Comparison (n = 15) Total (n = 28)
Mean (SD)
M(SD)
Age
Gender
Male
Female

38.3 (9.6)

35.3 (8.6)

36.7 (9.1)

9 (69.2%)
4 (30.8%)

10 (66.7%)
5 (33.3%)

19 (67.9%)
9 (32.1%)

Race
African-American
8 (61.5%)
12 (80.0%)
20 (71.4%)
Caucasian
5 (38.5%)
3 (20.0%)
8 (28.6%)
Note: None of the between group differences were significant at the p .05 level

the treatment group. The racial mix in the two groups was similarly distributed.
None of the between group differences were significant, suggesting that the
groups were comparable.
HIV/AIDS Status and Hypothesis 1 (Days in Treatment)
There is no significant difference between the treatment and comparison
groups in the mean number of days in treatment of those who were HIV/AIDS
positive. However, setting aside the treatment and comparison groups, nonHIV/AIDS subjects have a significantly higher mean number of days in treatment
than HIV/AIDS positive clients (t = 3.022, df = 104, p = .003, n = 106). Figure 5
shows the mean number of days in IOP care by treatment/comparison group and
HIV/AIDS status/non. Figure 5 shows that AOD clients who are HIV/AIDS
negative are in treatment the longest, 43 days for the comparison group and 37
days for the treatment group (first two bars in Figure 5).
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Figure 5. Mean number of days in treatment by group and HIV/AIDS status
(p .024)

HIV/AIDS Status and Hypothesis 2 (Treatment Completion)
Of the 28 HIV/AIDS positive subjects, five (18%) completed treatment, 2
in the treatment group and 3 in the comparison group (chi-Square = 2.385, df =
1, p = .123, n = 28). Due to the low number of HIV-infected subjects entering the
program, data analysis was limited. Analyzing the effects of the MI booster
sessions attended on completing treatment using cross tabulation resulted in too
many cells with expected frequencies less than five, thereby not generating a
valid statistical result. However, the counts and percentages are in Table 7.
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Table 7
Treatment Completion by HIV/AIDS Status
Treatment
Dropped Out
Completed
Total

Comparison

Total

11

84.6%

12

80.0%

23

82.1%

2

15.4%

3

20.0%

5

17.9%

13

100.0%

15

100.0%

28

100.0%

Supplemental Analyses
Three additional supplemental analyses were conducted to attempt to
explain the results of the study. In these analyses, only the number of IOP
sessions dependent variable was used, since completion status is a function of
the number of IOP sessions attended. In other words, number of days in
treatment dictates completion, making it a circular exercise, or redundant.
The first supplemental analysis was conducted to investigate the
influence of 10 subjects in the treatment condition (who included to satisfy an
intent to treat test, in bold in Table 8), and who received no MI sessions on the
outcome, the number of IOP sessions.2 Table 8 shows the mean, median, mode
and standard deviation of MI sessions provided to the treatment group, along
with frequency of sessions attended.
The median number of sessions received by those in the treatment group
(n = 50) was 2. In order to control for the possible effect of not attending any MI
sessions, the 10 subjects who received no MI sessions were excluded from the
treatment group in this analysis only. Table 9 shows the descriptive statistics for
2

Ten subjects assigned to the treatment condition left treatment prior to meeting with the
MI counselor, thus they received no MI sessions. As stated earlier, these subjects were
included in the original analysis of both hypotheses.
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Table 8
Number and Frequencies of Motivational Interviewing Sessions
Mean

Median

2.1

Mode

2

Motivational Interviewing Sessions
0
1
2
3
4
5

Standard
Deviation
1.5

3

Frequency
10
9
9
12
8
2

%
20
18
18
24
16
4

Table 9
Descriptive Statistics of Total Sample and After Exclusion
Sample Variables

N

Age at Admission
Total Sample
Treatment
Comparison
Treatment after
Exclusion
Gender

Mean
Percentage

Mode

34.4
34.7
34.1
34.6

28
19
41
19

106
50
56
40

Total Sample
Treatment
Comparison
Treatment after Exclusion
Race
Total Sample
Treatment
Comparison
Treatment after
Exclusion
HIV/AIDS Status

Black
47 47.2%
24 48.0%
26 46.4%
20 50.0%

55
26
29
19

52
24
28
18

White
49.1%
48.0%
50.0%
45.0%
Negative
78
73.6%
37
74.0%
41
73.2%
28
70.0%

Total Sample
Treatment
Comparison
Treatment after Exclusion

3

Female
51.9%
52.0%
51.8%
47.5%

Native American Indian

58

Range

19 - 63
19 - 59
19 - 63
19 - 59

Standard
Deviation
9.7
9.4
10.1
9.5

Male
51
48.1%
24
48.0%
27
48.2%
21
52.5%
NAI3
2
1.9%
1
2.0%
1
1.8%
1
2.5%

Hispanic
2 1.9%
1 2.0%
1 1.8%
1 2.5%

Positive
28
26.4%
13
26.0%
15
26.8%
12
30.0%

the truncated treatment group (data for the full treatment group are also
presented for comparison purposes) and the comparison group.
Results of a t-test indicated that there was no significant difference
between the truncated treatment and comparison groups in mean number of IOP
sessions attended (t = .178, df, 94, p = .859). Thus the inclusion or exclusion of
the 10 subjects in the treatment group who received no MI sessions did not
significantly influence the number of IOP sessions attended.
A second supplemental analysis included both univariate and multivariate
analyses to better understand the differences and similarities in the correlates
and predictors of the number of IOP sessions attended. First, correlations among
demographic variables, independent variables, additional measures, and
dependent variables (Table 2) were analyzed. Variables that were significantly
related to the primary outcome, number of IOP sessions attended, were retained
for inclusion in the multivariate analyses. A multiple regression was conducted to
identify those variables that accounted for a significant proportion of the variance
in the outcome. In the first block, any variable, with the exception of the primary
independent variable (treatment vs. comparison group), that was found to be
significantly related to the outcome in the bivariate analysis was entered. In the
second block, the treatment condition was entered. Table 10 presents the
correlation matrix of age, gender, race, HIV/AIDS status, number of MI sessions,
number of IOP sessions, completion, MI dose, and client severity.
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Examination of Table 10 indicates that two variables were significantly
related to the outcome (number of IOP sessions): HIV/AIDS status and client
severity. While the relationship between number of MI sessions and number of
IOP sessions did not reach the conventional level of significance, it was
approaching significance (p = .065).

Table 10
Correlation Matrix
1
1. Age
2. Gender
.074
3. Race
.087
4. HIV
-.016
Status
5. # of MI
-.011
sessions
6. # of IOP
.005
sessions
7. Completion .031
8. MI Dose
.043
9. Client
-.135
Severity

2
.074

3
.087
-.065

4
-.016
*-.237
**-.286

5
-.011
.145
.277
-.040

-.065
*.237
.145

**-.286
.277

-.040

-.066

*.221

**-.284

.263

.079
.206
*.204

-.004
*.332
.131

-.150
-.066
-.091

.103
**.862
.085

6
.005
-.066
.221
**-.284

7
.031
.079
-.004
-.150

8
.043
.206
*.332
-.066

9
-.135
*.204
.131
-.091

.263

.103

**.862

.085

**.633

.122

**.453

-.053

**.258
.020

**.633
.122
**.453

-.053
**.258

.020

Pearson’s correlations: * = Significant at p<.05; ** Significant at p <.01 (2-tailed).

Three variables were retained for inclusion in the multivariate model:
HIV/AIDS status, client severity, and number of MI sessions attended. Although
the number of MI sessions failed to yield a significant relationship with the
primary outcome, it was retained in the multivariate analysis because it
approached significance and was a major component of both hypotheses. Table
11 shows the unstandardized regression coefficients (b), standard errors (SE),
and standardized beta for the regression model. The linear combination of
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variables in the multivariate model accounted for 32% of the variance in the
number of IOP sessions attended. Examination of Table 12 indicates that client
severity and HIV status were significant predictors of the number of IOP sessions
attended. Given the findings in the bivariate analysis, it was not surprising that
the number of MI sessions attended was not a significant predictor of the
outcome, number of IOP sessions attended.
The fact that the 2nd block is not significant indicates that the severity and
HIV/AIDS status were significant at predicting number of IOP sessions (r2 change
= .315, f= 10.801, df= 47, p, = .000). However, even when controlling for effects
of severity and HIV/AIDS status, MI group involvement was not significant at
predicting number IOP sessions (r2 change = .042, f = 3.042, df = 46, p. =.088)

Table 11
Unstandardized Regression Coefficients
Dependant Variable = Number of IOP Sessions Attended
Model 1
Variable
Client Severity
HIV Status

Beta Coefficient

Std. Error

27.995**

6.882

-24.107**

7.743

Beta Coefficient

Std. Error

3.819

2.19

Model 2
Variable (excluded)
MI Sessions
*Significant at p <.05; ** Significant at p <.01.
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Table 12
Relationship between HIV/AIDS & Client Severity
HIV/AIDS Negative

HIV/AIDS Positive

Severe

31 (39.7%)

14 (50.0%)

45 (42.5%)

Not Severe

47 (60.3%)

14 (50.0%)

61 (57.5%)

78 (100.0%)

28 (100.0%)

106 (100.0%)

Total

Total

The third and final supplemental analysis was a chi-square testing the
relationship between HIV/AIDS status and client severity (Table 12). This
analysis was done to determine if the most severe clients were those who were
HIV/AIDS positive. Overall, 45 of the subjects (42.5%) were severe, including
39.7% of the HIV/AIDS negative and 50% HIV/AIDS positive. Those subjects not
severe totaled 61 (57.5%) with 60.3% HIV/AIDS negative and 50% HIV/AIDS
positive. This final supplemental analysis resulted in a non-significant relationship
(chi-square = .887, df = 1, p .379, n = 106).
Summary of Results
Neither of the two hypotheses were supported. Contrary to the MI
literature, an average of two MI booster sessions did not result in subjects in the
treatment group attending more IOP sessions or completing treatment for
addiction to alcohol and other drugs. Supplemental analyses, however, showed a
statistically significant relationship between HIV/AIDS status, severity (or the
degree to which clients appeared to be sufficiently stable to be located for
followup assessments), and days in IOP treatment: HIV/AIDS positive clients
perceived as high in severity were more likely to drop out of treatment.
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CHAPTER V
DISCUSSION AND IMPLICATIONS
The results of this study suggest that additional Motivational Interviewing
sessions within the first two weeks of treatment do not increase the number of
days in intensive outpatient treatment for VOA’s clients addicted to alcohol and
other drugs, some of whom are also HIV/AIDS positive. Neither is there a
statistically significant relationship between having/not having additional
Motivational Interviewing sessions in the first two weeks of treatment and
completing treatment. The first reaction to this news is to search for flaws in the
research design, and the most prominent error was this designer’s
misunderstanding of the exact nature of clients’ problems. For example, this
researcher underestimated the magnitude of the impact of myriad negative
factors in clients’ histories, relationships, and social environments that have
resulted in their current predicaments: addicted to alcohol and other drugs, and in
26% of the sample, positive for HIV/AIDS. In hindsight, how could a few
motivational sessions overcome lifetimes of negative influences?
Implications of Theoretical Perspectives
This final chapter begins with examining the implications of this study
relating to the theoretical perspectives that provided guidance. Some
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weaknesses and oversights will be discussed along with study design flaws. It
concludes with knowledge gained and recommendations for future research.
Looking back at the theoretical perspectives of Rogers and Prochaska
and how those perspectives informed and guided this study, is important for the
future direction of researching this specific population. From Rogers’ perspective
we are born with a positive valuing process that enhances and maintains those
positive things in our lives, and devalue negative experiences that stagnate our
growth potential. Rogers (1951, 1961, & 1980) concluded that our worlds are of
our own making (our reality) and that in order for someone else to understand
our real realities they must attempt to place themselves in our frames of
reference. Once we can truly understand ourselves, we seek positive regard for
that self.
Rogers’ (1951, 1961, & 1980) goal in treatment is basically what should
happen during treatment. The therapist should be empathic always with an eye
toward valuing the client. As stated earlier, this provides a venue and justification
for intervening with the Motivational Interviewing approach. Successfully applying
MI during a counseling session is to be empathic with the client, or as Miller and
Rollick (2002) claim, MI is a way of being with people.
Focusing on what happens during the therapy process is vital. However,
what was discounted during this study (as well as Rogers’ theoretical
underpinning [1951, 1961, & 1980]) was the limited resources the client brings to
therapy sessions. This theoretical perspective assumes that the client has sound
personal agency outside of the therapeutic arena, and that the identified problem
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at hand can be the main focus during its treatment. Unfortunately, for many
individuals entering into treatment, the power of during treatment therapeutic
empathy cannot revise the rule of 24/7 poverty. Can a therapist meet the level of
being empathic while working under the assumption that the lack of motivation or
poor personal agency is the cause, and targeting it can be the cure?
Methodological Limitations
There was a departure from sequential random sampling. Because those
who entered the program being addicted to alcohol and other drugs as well as
suffering from HIV/AIDS made up a much smaller segment, one adjustment was
made to better balance experimental and control groups. After several months of
sequential assignment and close to the end of the study, a decision was made to
place the next HIV/AIDS subject into the comparison group in order to balance
out the two groups. This adjustment violated assumptions of random sampling.
Another limitation was not monitoring the intervention for fidelity. While the MI
counselor was well seasoned, trained, and credentialed, it is not known whether
the proposed protocols were followed as none of the sessions were observed or
taped.
The sample and statistical power are also small. However, Rounsaville et
al. (2001) noted that small pilot studies of 15 to 30 subjects per group are
necessary in Stage 1b of intervention development research. The sample is a
single site community of people receiving addiction treatment; therefore, the
results cannot be generalized to other populations.
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Another study limitation was not obtaining baseline data related to
possible factors which were contrary to treating addiction at the most minimum
level of care--outpatient. Although randomization would seemingly have solved
baseline differences, it cannot be assumed that clients living in poverty are
outliers and would be equally distributed. The majority of subjects in the study
could have enormous external forces working against remaining in minimal care.
This could explain the 70% termination from treatment before completion. To
think that a few empathic Motivational Interviewing sessions during the first two
weeks of IOP treatment could overpower the awesome forces this population
deals with on a daily basis was blatant naivety.
Based on working in the Volunteers of America system for about 10 years,
it is clear that the most common characteristic of VOA clients is that they live in
poverty which is commonly overlooked and misunderstood. In addition, a majority
of clients entering this VOA program do not have stable living arrangements or
even the most basic necessities. They have histories of chronic medical
dilemmas (e.g. diabetes, HIV/AIDS, Tuberculosis, and Hepatitis) along with the
lack any health care services. While they may live within walking distance of
some of the best health care facilities in the world, they are denied that care
because they have no jobs and little/no income or insurance. They also present
with multiple addictions beginning early in life and developing into chronic
conditions that are much more difficult to treat. Involvement in the criminal justice
system is something that is simply expected. Due to the intergenerational effects
of poverty, this population is also deficient in any social or family support
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stemming from the intergenerational effects of poverty. Having entered into
addiction treatment services, all of those co-evolving problems continue without
regard to the best intentions of the empathic Motivational Interviewing therapist.
The individual suffering from these problems could be considered to be
pauper type addicts. This is not an attempt to coin a clever label, but a
suggestion for a new way of thinking and treating a unique person who requires
specific services. Many times this cohort is labeled as homeless. But that does
not get to the marrow of what is occurring in their lives. The homeless identity
also sends a message to the professional helper about which problem to deal
with first. The pauper type addict’s assessed problems cannot be hierarchically
ranked and dealt with one at a time. Their problems are like Aspens, where
people like to vacation—the trees bloom together because they are connected by
their roots. So must the problems of such clients be addressed together—
because they are connected by their roots.
This study was guided by the Transtheoretical Stages of Change model
(Prochaska & DiClemente, 1983, 1984). Unfortunately, when treating the pauper
type addict for addiction, this model seems to also overlook the unique, coevolving problems of the sufferer. The stages-of-change-model consists of how
and why people change on their own as well as with some type of professional
assistance. The model describes a set of predictable stages through which
people travel in the course of altering addicted behavior: Preconception,
Contemplation, Determination, Action, and Maintenance. The groundwork for this
model came from working with tobacco addictions and expanded to other
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behavioral problems. Working within the stages of change framework seems to
require the dedicated attention toward that central, one and only, specifically
identified problem. As a specific problem is addressed, the individual, along with
the therapist, monitors that particular stage of change in order to adequately
adjust the therapeutic intervention.
The goal is to move through the stages as smoothly as possible. There is
an acceptance that while working on that problem one could move both
backward and forward through the stages. So the individual and therapist have
one problem and five different stages to monitor. The pauper type addict could
have up to five equally serious problems to address (i.e. housing, employment,
addiction, medical, and criminal justice). This would require monitoring five coevolving problems with five different fluid stages. Because each individual
problem is influenced and connected to every other problem (e.g. obtaining
adequate housing would require being able to pay rent, which would also require
employment, resulting in limiting the time it takes to treat addiction), monitoring
the stages of change and intervening appropriately would be almost impossible.
The therapist would have to keep track of five specific and connected problems
with five different stages for each problem, resulting in at least 25 possible
intervention opportunities that are constantly evolving and moving in every
direction (easier said than done!).
Smoking is a straightforward problem to deal with using the stages of
change model. It is one problem that can take a back seat when a more serious
problem arises. Usually it does not require entering into a treatment facility for
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several hours weekly and lasting several weeks or even months. Treating the
problem of smoking can also be postponed or even discouraged if a more
serious problem occurs. Smoking clients are normally not under the pressures of
going to jail, losing their jobs, being evicted or even losing custody of their
children for discontinuing the smoking treatment due to a more serious issue
arising in their lives. It is a matter of prioritizing problems.
This is not the case with addicts or pauper type addicts who are involved
in addiction treatment. If they postpone or discontinue addiction treatment,
serious consequence may ensue. While there could be more serious problems
arising in the life of pauper type addicts during addiction treatment services, if
they drop out of those services, it is usually seen as a lack of motivation, or in
other words, the client is held responsible by being described as noncompliant.
While the stages of change seemed to be an appropriate framework, it
may be limiting when dealing with an addicted population with multiple problems
requiring an array of change stages to monitor. And while Motivational
Interviewing and the stages of change may rely too heavy on client personal
agency (an internal motivational flaw), lacking regard for any other external
forces at work.
Research Inclusion and Exclusion Activities
Having re-examined the MI literature to provide more background for the
intervention, many studies have specific inclusion/exclusion criteria. For example,
Project MATCH excluded those who were homeless and involved in the criminal
justice system. A randomized trial in drug abuse services conducted by Miller
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and Rollnick (2002) provided Motivational Interviewing sessions to patients in
order to elicit behavior change by exploring and resolving ambivalence. They
enrolled 152 outpatient and 56 inpatient clients who were entering a public
agency for drug problems. The researchers reported and excluded clients if they
reported insufficient residential stability.
This is not an attempt to take away from the credibility of Motivational
Interviewing or any Motivational Interviewing research. It seems to work very well
with specific groups in specific environments. Future interventions must include
every client entering the facility under study (within the parameters of informed
consent) or they will not represent real world clinical activities.
After realizing the weakness of not collecting any baseline data, an effort
was made to obtain information about subjects’ treatment histories. Because the
VOA outpatient clinic is funded by SAMSHA-CSAT it is required to treat a
specific number of clients. SAMSHA-CSAT mandates treatment programs to
gather baseline data on clients who enter these programs and enter these data
into SAMSHA-CSAT’s on-line data system, Government Performance and
Results Act (GPRA). Once a program enters the client’s baseline data into the
system, SAMSHA-CSAT mandates 6 and 12-month followup with these clients. If
programs are unable to obtain an 80% followup rate for six and 12 months, the
program could lose funding. It is recommended that in order to obtain the 80%
follow up rate, programs must be careful when deciding who they enter into the
GPRA system. If a client presents as difficult to follow up (e.g., unstable living
arrangements or homeless, pending legal charges, and/or recent move from out
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of state) the program may provide treatment, but not enter this hard to followup
client into the GPRA.
Of the 106 subjects entering this study, 45 (42.5%) were evaluated to be
hard to followup clients and not entered into the GPRA database. While they
were accepted into IOP treatment, the pressure of locating them at 6 and 12
months was relieved. This practice is not uncommon in research designs, in
order for research results to be accepted, a specific follow rate is mandated.
However, the only significant finding resulting from this study was between those
subjects who were evaluated as hard to follow compared to those subjects
evaluated as appropriate to enter into the GPRA database and locating at 6 and
12 months.
Those subjects entered into the GPRA (those evaluated as being stable
enough to find at 6 and 12 months) remained in IOP treatment significantly
longer than those subjects who were evaluated as hard to follow up (t = -5.180,
p. = .000). The relationship between treatment completion and being entered into
the GPRA database was also significant. A higher percentage of clients not
entered into the GPRA (hard to follow) dropped out of treatment compared to
those who were entered into the GPRA database (Chi-Square = 7.082, df = 1, p
.008).
These findings relate back to subject exclusion based on research
requirements that demand specific followup rates. While subjects meeting
research inclusion criteria and entered into studies produce higher followup rates
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and acceptable data analyses, the effects of research exclusion could have
significant clinical effects on those excluded from research.
Treatment as Usual
The final implication is the idea of treatment as usual. This study did not
speak extensively to the specific treatment being offered to subjects and how it
relates to generalizable outcomes. An assumption of the current design was that
everyone receiving treatment as usual served as a control for both groups. Never
considered was the question of, what is usual treatment? Does treatment as
usual mean the best evidence-based treatment being offered? The assumption
made when using treatment as usual is that as long as both groups get it,
treatment quality does not matter.
Treatment as usual without examining its quality, limits the study’s
generalizability, as well as the knowledge needed to inform best practices. For
instance, if a study was designed to investigate the effects of medication on
retention and completion within a tuberculosis clinic, treatment as usual would
have to be the best, medically agreed upon activity. Let’s agree that the standard
practice for treating and curing tuberculosis consists of taking four antituberculosis drugs over the course of six months. This would be treatment as
usual due to its empirically based results. It cures tuberculosis without regard to
geographic, socio-economic, or basic human demographic differences. The only
problem with the tuberculosis therapy is that the sufferers are dropping out of the
treatment regimen.
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An investigation to understand tuberculosis treatment retention and
completion would be a worthy cause. Treatment compliance would ensure the
elimination of tuberculosis. If conducting a study in a tuberculosis clinic it must
provide these four medications in order to be considered treatment as usual.
However, let say that due to cost constraint and the inability to treat every case of
tuberculosis, there is a clinic in town (the Volunteer Clinic) that treats those who
suffer for tuberculosis who do not have the necessary health care coverage to be
treated in local prestigious clinics. While this volunteer clinic provides those same
medications, it cannot afford them in the correct dosage. The volunteer clinic
provides lower doses of the standard medications resulting in the treatment
lasting twice as long. Therefore, the six months of treatment now must take a
year. And for that individual whose untreated tuberculosis has caused greater
medical complications, receiving the minimum treatment dose over a longer
period of time cannot be quality care. Could this volunteer clinic be considered
and studied using treatment as usual? Could the retention and completion
findings at the volunteer clinic be generalized to other tuberculosis clinics
providing substandard care? Are there research ethics involved in this real world
dilemma? (Not to worry, the Institutional Review Boards are concerned with
protecting people from research—not clinical services.)
Knowledge building becomes limited without knowing specifically how
treatment as usual is being used within the research design. Treatment as usual
should also be evaluated and clarified for its effectiveness on the problem being
studied before accepted as a controlled research condition. This study, while not
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taking these issues in account, cannot produce the knowledge for which it was
searching.
Future Research
Future research should address the outside influences on subjects. For
instance, relying only on an in-treatment intervention without addressing housing
issues, unemployment, medical conditions, or other overpowering forces
requiring the immediate attention of the client, would have a limiting effect on
outcomes. This study could be replicated using a case manager working to
stabilize outside issues thereby allowing the subject to focus on remaining in
treatment and only treating addiction. A case manager could assist with limiting
the pressures of outside issues pulling subjects away from the priorities of
treatment.
The same would be true of the addicted HIV-infected population coming
into treatment. However, following Rounsaville, Carroll, and Onken’s (2001)
Stage 1b Pilot Trial model for research when including those who are HIVinfected into addiction treatment would require a greater amount of time in a
larger study. Because this population usually requires many levels of care as well
as being hard to follow, enrolling them into research studies demanding rigorous
followup could be difficult.
This study was able to adhere to some of the Stage 1b Pilot Trial’s aims.
Alcohol and other drug addicted HIV/AIDS positive subjects were retained long
enough to receive the intervention. This study was also able to recruit sufficient
numbers of the targeted population to deliver the intervention and analyze some
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data. However, one aim was to obtain a clinically significant outcome on at least
one important domain, which did not occur.
The recommendation for future research with a larger sample of those who are
alcohol and other drug addicted would also apply to those entering HIV-infected.
Connecting this population with a case manager who understands both disease
conditions and is able to operate within the community to bring together
appropriate services is vital to any further research.
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Description of Volunteers of America of KY Intensive Outpatient
Alcohol/Drug Treatment

Program Description: The Outpatient Clinic has been designed to offer Gender
Specific Programming for both men and women who are HIV positive, and/or at
high risk for HIV and alcohol/drug dependent. The program is to provide persons,
who are HIV and alcoholic/drug dependent, treatment and case management
services. There are two separate Intensive Outpatient tracks: one for women and
one for men the women meet from 9:00 am - 1:00 pm, and the men meet from
1:00-5:00 pm, Monday through Friday. We offer childcare for both women and
men who have children while they are in treatment.
Admission Criteria: Eighteen years or older who are alcohol/drug dependent
with HIV and/or at high risk for HIV.
Services Offered: The services provided are gender specific 90 minute group
counseling sessions, Recovery Dynamics, life skills, vocational and career
development, parenting classes, health issues, domestic violence counseling,
intensive case management/outreach services and continuing care services. The
program also has the capability to provide psychiatric consult and evaluation. We
also provide childcare services and referrals for child enrichment programs.
Contact Person(s) Lynda Durrett, Program Manager or Deb Reinhardt, Director
of Women’s Outpatient & Alcohol Drug Programs office: (502)635-4513 fax:
(502) 636-0597.
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APPENDIX B
Human Subjects Protection Program Office’s Institutional Review Board
(IRB) Amendment to Reflect the Addition of Up to Five Additional
Motivational Interviewing Sessions
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STUDY TITLE: Technical assistance and program evaluation (longitudinal
followup study) of the Volunteers of America targeted expansion initiative for
substance abuse and HIV prevention in minority communities. (CSAT # TI-14491 &
TI-15852)
Subject Informed Consent
Introduction and Background Information: You are invited to participate in a research
study.
The study is being conducted by Richard N. Cloud, Ph.D. and Linda K. Bledsoe, Ph. D.
The study is sponsored by the University of Louisville Kent School of Social Work and a
grant from the federal department of Health and Human Services, Substance Abuse and
Mental Health Services Administration, Center for Substance Abuse Treatment (CSAT)
that was awarded to Volunteers of America (VOA). Money from the grant is being paid to
the University of Louisville, Kent School of Social Work to conduct this study. The study
involves your involvement in two interviews that will take place at the VOA or some other
agreeable site. Approximately 200 subjects will be invited to participate. Your
participation in this study will last for one year following treatment.
Purpose: The purpose of this research study is to test effectiveness of the VOA
treatment program at reducing substance abuse and to reduce practices known to
spread HIV/AIDS. Your involvement in the study will consist of two interviews expected
to last about one hour each. These two interviews will be conducted at approximately six
and twelve months following the date that you started treatment at VOA.
Procedures: At these two interviews, you will be asked to complete many (but not all) of
the questionnaires that you completed when you signed up for the VOA treatment
program. One questionnaire includes several questions related to how your life is going
in general, substance abuse, and practices known to spread HIV/AIDS. In addition, we
will be asking you to complete four questionnaires that provide information on conditions
that are known to reduce substance abuse, including: AA and NA involvement;
motivation to stay clean and sober; support from friends; and temptation to use drugs
and alcohol. In general, we will compare responses of subjects at the time treatment
began to responses to the same questions six and twelve months later. You may refuse
to answer any question that makes you uncomfortable.
Additionally, some people may be asked to participate in one to five more motivational
counseling sessions in order to see if it increases your retention in treatment services. If
you agree to participate in these additional interviews, please complete the checkboxes
below:
You agree to participate in the additional counseling sessions
Initial Here
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You do not want to be contacted for the additional sessions

Initial Here

Potential Risks: There is a risk that participating in the study could lead to a breach in
confidentiality. This means people could learn of your participation in the study. Since
the program is treating substance abuse among those who have HIV and those at risk of
contracting HIV, this information could result in some form of discrimination. For this
reason, it is critical that you are careful to maintain absolute confidentiality of the other
participants in treatment. We are taking several steps to safeguard confidentiality of
participants. In addition, some of the questions on illicit drug use and sexual practices
could be incriminating. Because of this we have sought legal protection to reduce a
highly unlikely risk that a court might subpoena these records (see Certificate of
Confidentiality below). In addition, there may be unforeseen risks that cannot be
anticipated.
Certificate of Confidentiality: To help us protect your privacy, we have obtained a
Certificate of Confidentiality from the federal government. With this Certificate, the
investigators cannot be forced (for example by court subpoena) to disclose your name or
other information that may identify you in any federal, state, or local civil, criminal,
administrative, legislative, or other proceedings. The Department of Health and Human
Services (DHHS) may see your information (only for audit or program evaluation), and
we may voluntarily disclose information if we think harm to yourself or others, including
child abuse, is probable. None of this implies DHHS approval or disapproval.
If an insurer, employer, or other person obtains your written consent to receive research
information, then the researchers may not use the Certificate to withhold that
information. The Certificate of Confidentiality does not prevent the researchers from
disclosing voluntarily, without your consent, information that would identify you as a
participant in the research project under the following circumstances: if we should
become aware of any act of child abuse, or any intent to harm yourself or another
person during the course of the interview.
Confidentiality: Although absolute confidentiality cannot be guaranteed, we are taking
steps and are committed to protecting your privacy. The study sponsor, the Institutional
Review Board (IRB), the Human Subjects Protection Program Office (HSPPO),
personnel conducting the research including those from the Kent School of Social Work
may have access to research records. Should the data collected in this research study
be published, your identity will not be revealed.
Benefits: The possible benefits of this study include helping VOA to do the research that
they agreed to do in their agreement with CSAT, which in turn, will help to insure that
VOA continues to receive money to pay for future substance abuse treatment services
benefiting both you and others. In addition, while the information collected may not
benefit you directly, what is learned may benefit VOA and American society by leading to
improved methods to treat substance abuse and to reduce the spread of HIV.
Compensation: You will receive $20 for completing the six-month and the twelve-month
interviews ($20 for each interview or $40 for both interviews). Those agreeing to
participate in the additional counseling will not be paid extra.
Voluntary Participation: Your participation in this research study is voluntary. You may
refuse to participate and you are free to withdraw your consent at any time without
penalty or losing benefit to which you are otherwise entitled.
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Research Subject’s Rights and Contact Persons: You acknowledge that all your present
questions have been answered in language you can understand and all future questions
will be treated in the same manner. If you have any questions about the study, please
contact Richard N. Cloud, Ph.D. at 502-299-1385.
If you have any questions about your rights as a research subject, concerns or
complaints about the research or research staff, you may call the HSPPO at 502-8525188. You will be given the opportunity to discuss any questions about your rights as a
research subject, in confidence, with a member of the IRB. The IRB is an independent
committee composed of members of the University community, staff of the institutions,
as well as lay members of the community not connected with these institutions. The IRB
has reviewed this study.
Consent: You have discussed the above information and hereby consent to
voluntarily participate in this study. You will be given a signed copy of the
consent.
___________________________________________
Signature of Subject

___________
Date Signed

___________________________________________
Person Explaining the Consent

__________
Date Signed

___________________________________________
Signature of Investigator

___________
Date Signed
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Motivational Interviewing
Protocol for Sessions on Retention
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Motivational Interviewing
Protocol for Sessions on Retention
Sources of Non-Adherence

Motivational Strategies

Uncertainly or ambivalence
about change

Persistent empathy and non-defensiveness

Concerns about the suitability
of the treatment modality
offered

Normalizing gradual development of trust

Misperceptions about treatment
needs

Exploring understanding of how treatment
works

Previous negative treatment
experiences

Eliciting perceptions of treatment needs

Negative general relationship
expectancies

Decisional balancing

Culture-specific differences

Reviewing past treatment experiences

Stigma

Exploring and addressing previous and future
barriers to change in treatment

Mandated treatment/coercion

Negotiating proximal goals

High barriers to care (financial
problems, family hardships)

Communicating a non-perfectionist message

Low self-efficacy in handling
treatment demands

Recognizing non-adherence as a sign of
damaged rapport
Addressing breeches in rapport
Involving a supportive other for motivational
support
Identifying positive experiences of receiving
help
Supporting self-efficacy or coping capacities
Displaying optimism about treatment
effectiveness
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sponsored by SAMHSA and Volunteers of America of KY and TN.
Cooper, L., Cloud, R. N., Hill, J., McKiernan, P., & Patterson, D. A. Results of a
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